对初级输血淋巴瘤的有希望的免疫治疗方法
Jutatip Panaampon1,2,3, Seiji Okada3
1Division of Hematologic Neoplasia, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Exploration of targeted anti-tumor therapy
|July 5, 2024
概括
主要输液淋巴瘤 (PEL),一种与艾滋病相关的癌症,尽管结合抗逆转录病毒疗法,预后不佳. 迫切需要新的免疫疗法来改善PEL患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 病毒学 病毒学
背景情况:
- 初级输出性淋巴瘤 (PEL) 是一种与艾滋病相关的侵袭性非霍奇金淋巴瘤,其特点是体腔中的恶性输出.
- PEL与人类疹病毒8 (HHV-8) /卡波西肉瘤相关的疹病毒 (KSHV) 感染有关.
- 尽管联合抗逆转录病毒疗法 (cART) 取得了进展,但PEL的预后令人丧,在标准化疗中成功程度有限.
研究的目的:
- 审查关于PEL免疫治疗方法的当前知识和最近的临床试验.
- 探索PEL免疫疗法的有希望的未来方向.
主要方法:
- 对PEL治疗现有文献和临床试验数据的审查.
- 免疫治疗策略的分析及其对PEL的潜在应用.
主要成果:
- 标准化疗方案 (例如CHOP) 在PEL中显示出令人失望的结果.
- 免疫疗法是新型治疗策略的一个有希望的途径.
结论:
- 迫切需要新的治疗方法来治疗PEL.
- 免疫疗法对改善PEL患者的临床结果具有显著的前景.
相关概念视频
01:27Tumor Immunotherapy
509
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
509
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K